Contact
searchSearch
HMP Global
Login

January/February 2018

Feature

From the Field
Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer
02/15/2018
Bruce A. Feinberg, DO; Chadi Nabhan, MD, MBA, FACP
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...
Abstract: Clinical...
02/15/2018
Journal of Clinical Pathways
Research Reports
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting
02/15/2018
Michael A. Savin, MD; Ravi Salgia, MD, PhD; Blase Polite, MD; Corey Shamah, MD; Mark A. Socinski, MD; Amanda Barry, MPH; Kathy Lokay; Peter G. Ellis, MD; Casey Mason; Ray Page, DO, PhD, FACOI, FASCO; Natalie Dickson, MD
Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC),...
Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC),...
...
02/15/2018
Journal of Clinical Pathways

Column

Pharma Insights
How Variations in Health Systems Influence Oncology Practices
02/15/2018
Ashwin Athri, MBA
Changing marketplace dynamics related to the demographics and economics of cancer care is making it necessary for health systems to adapt and invest in capabilities ranging from care coordination models to a...
Changing marketplace dynamics related to the demographics and economics of cancer care is making it necessary for health systems to adapt and invest in capabilities ranging from care coordination models to a...
...
02/15/2018
Journal of Clinical Pathways
Clinical Pathways GPS
Who Really Controls Treatment Selection? It`s Not Always Who You Think
02/15/2018
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
New policies and legislation related to health care reform mean that control over treatment selections may also shift within different markets. For professionals creating a clinical pathway for a disease state, it is...
New policies and legislation related to health care reform mean that control over treatment selections may also shift within different markets. For professionals creating a clinical pathway for a disease state, it is...
New...
02/15/2018
Journal of Clinical Pathways
Editor's Page
Utilizing Pathways Among Shifting Market Dynamics
02/15/2018
Winston Wong, PharmD
As the health care system collectively progresses toward full adoption of the Medicare Access and CHIP reauthorization Act, providers, practices, and health systems have been working to understand the full impact of...
As the health care system collectively progresses toward full adoption of the Medicare Access and CHIP reauthorization Act, providers, practices, and health systems have been working to understand the full impact of...
As the...
02/15/2018
Journal of Clinical Pathways
Department
How Christiana Care and Strata Precision Oncology Are Making No-Cost Tumor Profiling and DNA Sequencing More Accessible
02/15/2018
Researchers in cancer care have made great strides in recent years. Contributing to these advancements is the new ability to sequence tumors from cancer patients in order to determine specific gene mutations...
Researchers in cancer care have made great strides in recent years. Contributing to these advancements is the new ability to sequence tumors from cancer patients in order to determine specific gene mutations...
...
02/15/2018
Journal of Clinical Pathways

News

Conference Coverage
American Society of Clinical Oncology Gastrointestinal Cancer Symposium
02/15/2018
The American Society of Clinical Oncology (ASCO) hosted its annual Gastrointestinal (GI) Cancers Symposium in San Francisco, California, from January 18-20, 2018. The GI Cancers Symposium is a specialized oncology...
The American Society of Clinical Oncology (ASCO) hosted its annual Gastrointestinal (GI) Cancers Symposium in San Francisco, California, from January 18-20, 2018. The GI Cancers Symposium is a specialized oncology...
The...
02/15/2018
Journal of Clinical Pathways

Department

Research in Review
Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine
02/15/2018
Real-World Outcomes of Patients With NSCLC Treated With PD-1 Inhibitors After Approval Certain subgroups of patients with NSCLC are underrepresented in clinical trials for newly approved PD-1 inhibitors...
Real-World Outcomes of Patients With NSCLC Treated With PD-1 Inhibitors After Approval Certain subgroups of patients with NSCLC are underrepresented in clinical trials for newly approved PD-1 inhibitors...
...
02/15/2018
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use